Drug Delivery Market Size to Hit USD 2800.61 Million by 2029
Global Drug Delivery Market report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and their strategies such as new product launches, expansions, agreements, joint ventures, partnerships, and acquisitions which are applicable for the businesses with which they can take better steps to improve their strategies to sell goods and services. Market research presents actionable market insights which help create sustainable and money-spinning business strategies. An absolute way to forecast what future holds is to comprehend the trend today. Thus, with Global Drug Delivery Market business report, more important aspects of the HEALTHCAREindustry can be focused.
In recent years, the drug delivery market is anticipated to proliferate during the forecast period. According to the World Health Organization (WHO), chronic disease prevalence is expected to rise by 57% by the end of 2020, according to the World Health Organization (WHO). The desire for healthcare systems to focus more on advanced drug delivery technologies has risen rapidly in response to the rise in chronic diseases. Furthermore, there is a growing emphasis on product safety, efficacy, and patient-friendliness. The drug delivery market would increase in the approaching years due to the demand for sophisticated technologies to meet the rising demand for routine injectable pharmaceuticals to treat chronic illnesses.
Download PDF Sample Report (Including Graphs, Charts, and List of Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-drug-delivery-market&Shri
Data Bridge Market Research analyses that the drug delivery market was valued at USD 1458.19 million in 2021 and is expected to reach USD 2800.61 million by 2029, registering a CAGR of 8.50% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Drug delivery introduces a therapeutic effect in a human’s body by providing a drug to a certain targeted place. The safety and efficacy can be increased by adjusting the rate, time, and release of the drug in the body. Drugs can be delivered in a variety of ways, including oral, injectable, pulmonary, nasal, and other routes. The features of nanoparticles have been studied and used to develop drug delivery systems, which has made the process of drug distribution more efficient and time-saving.
Drivers
- Rise in the prevalence of chronic diseases
The rising prevalence of chronic diseases is estimated to propel the drug delivery market’s growth. Sedentary lifestyles have become commonplace as a result of rapid technological adoption. Obesity rates are rising as a result of this change in lifestyle, which is leading to a slew of chronic ailments such as diabetes and heart disease.
- Increasing investment for healthcare infrastructure
Another significant factor influencing the growth rate of drug delivery market is the rising healthcare expenditure which helps in improving its infrastructure.
Furthermore, rising initiatives by public and private organizations to spread awareness and technological advancement will expand the drug delivery market. Additionally, high disposable income and increasing adoption of advanced drug administration systems will result in the expansion of drug delivery market. Along with this, rising geriatric population and rising demand for biosimilars and biologics will enhance the market’s growth rate.
Recent Development
- In March 2022, Sandoz, a Novartis division, announced the acquisition of a UK-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce’s expertise and assets as part of the arrangement, which will help the company expand its respiratory medication portfolio and improve patient access to high-quality, complex therapeutics.
Some of the major players operating in the drug delivery market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (US)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France), Pfizer Inc. (US)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- Sun Pharmaceutical Industries Ltd. (India)
- Dr. Reddy’s Laboratories Ltd. (India)
- Bausch Health Companies Inc. (Canada)
- AstraZeneca (UK)
- Johnson & Johnson Private Limited (US)
- Merck & Co., Inc. (US)
- Cadila Pharmaceuticals. (India)
- 3M (US)
- Bayer AG (Germany)
- Astellas Pharma Inc. (Japan)
- AbbVie Inc. (US)
- Takeda Pharmaceutical Company Limited (Japan)
To Gain More Insights into the Market Analysis, Browse the Summary of the Research Report@ https://www.databridgemarketresearch.com/reports/global-drug-delivery-market?Shri
Top Key Topics Covered:
- Strategic Imperatives
- Factors Creating Pressure on Growth
- The Strategic Imperative
- Growth Opportunities Fuel the Growth Pipeline Engine
- Research Methodology
- Scope and Segmentation
- Research Context and Scope of Analysis
- Segmentation
- Other Techniques for This Research Report Management
- Growth Opportunity Analysis
- Growth Drivers
- Growth Restraints
- Introduction
- The Impact of the COVID-19 Pandemic and Post
- Future Growth
- Innovation Ecosystem
Continued…
Drug Delivery Market Scope
Product Type
- Oral Drug Delivery
- Pulmonary Drug Delivery
- Injectable Drug Delivery
- Ophthalmic Drug Delivery
- Nasal Drug Delivery
- Topical Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, ophthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery.
Application
- Cancer
- Diabetes
- Respiratory Diseases
- Cardiovascular Diseases
- Others
Based on application, the market is segmented into cancer, diabetes, respiratory diseases, cardiovascular diseases and others.
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
On the basis of end-users, the drug delivery market is segmented into hospitals, specialty clinics, homecare and others.
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
On the basis of distribution channel, the drug delivery market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Fundamental Aim of this Market Report
- Notable Market rivals around the world.
- Future Scope and Product Outlook
- Future-promising emerging markets.
- The Market Presents Difficult Challenges and Threats.
Key highlights of this Market report:
- Major restraints
- Market drivers
- Regional bifurcation
- Competitive hierarchy
- Current market tendencies
- Market concentration analysis
Browse the complete table of contents at – https://www.databridgemarketresearch.com/toc/?dbmr=global-drug-delivery-market&Shri
Critical Insights Related to the adalimumab biosimilar Included in the Report:
-
- Exclusive graphics and Illustrative SWOT analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Top DBMR Healthcare Reports:
https://www.databridgemarketresearch.com/reports/global-cardasil-treatment-market?Shri
https://www.databridgemarketresearch.com/reports/global-aestheticcosmetic-lasers-market?Shri
https://www.databridgemarketresearch.com/reports/global-yeast-infection-market?Shri
About Data Bridge Market Research:
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.
Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact Us:-
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com
